Latest News

Latest News

News from the World Hepatitis Alliance

Worldwide 52 million children living with viral hepatitis

3 Nov 2017 Tara Farrell

World Hepatitis Alliance calls for better screening expectant mothers and treatment of children New data presented at this year’s World Hepatitis...

Miracle cure costs less than a budget airline flight

2 Nov 2017 Tara Farrell

New data shows hepatitis C cure can cost as low as 50 dollars, and data from over 1,000 patients shows it’s highly effective Embargo: 0001H Sao Paulo...

Nine countries now on track to eliminate hepatitis C

1 Nov 2017 Tara Farrell

On 1- 3 November, Ministers of Health, public health experts and NGOs will come together at the World Hepatitis Summit to advance the elimination of...

World Hepatitis Alliance seeks experienced Finance Manager

16 Oct 2017 Bridie Taylor

An exciting opportunity has arisen for an experienced Finance Manager looking for a part time role to join our dynamic team and make a real...

Viral Hepatitis kills more people than HIV, malaria or tuberculosis

15 Sep 2017 Tara Farrell

World Hepatitis Alliance calls for immediate political action to counteract fatal trend [London, 14 September] According to the Global Burden of...

Hepatitis A vaccination for Alaskan children has wiped out the virus

10 Aug 2017 Tara Farrell

A comprehensive hepatitis A vaccination program established in Alaska in the 1990s, which became a requirement for school entry in 2001, has...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska’s young people

10 Aug 2017 Tara Farrell

Updated research presented at this year’s World Indigenous Peoples’ Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that...

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

9 Aug 2017 Bridie Taylor

A new meta-analysis of global hepatitis data -- presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska...

Cherokee Nation American Indian Tribe showing it is possible to eliminate hepatitis C

9 Aug 2017 Bridie Taylor

The Cherokee Nation American Indian population is aiming to eliminate hepatitis C virus (HCV) among its tribal citizens, where already almost half...

World Hepatitis Day sets the stage for the elimination of viral hepatitis - Press Release

28 Jul 2017 Tara Farrell

World Hepatitis Alliance calls for greater collaboration to reach 2030 World Health Organization targets...

An open letter to the Cochrane Collaboration

26 Jun 2017 Bridie Taylor

The members of the Executive Board of the World Hepatitis Alliance are elected to represent the more than 300 million people who have the experience...

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

13 Jun 2017 Tara Farrell

The World Hepatitis Alliance is concerned that the findings of the Cochrane Review on the new direct acting antiviral (DAA) hepatitis C drugs could...

World Hepatitis Alliance seeks Communications and Campaigns Officer

9 Jun 2017 Tara Farrell

Our dynamic Communications team is seeking an experienced Communications and Campaigns Officer to develop and implement our external facing...

Why do we continue to put our children at unnecessary risk of liver cancer?

6 Jun 2017 Bridie Taylor

On International Children’s Day (1June), the World Hepatitis Alliance calls for widespread coverage of the hepatitis B birth dose vaccine to protect...

WHO’s first Global Hepatitis Report sets baseline to measure progress towards the elimination of viral hepatitis by 2030

21 Apr 2017 Tara Farrell

London, 21 April 2017, The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO). The report comes as a follow-up to WHO’s Global Strategy on Viral Hepatitis, which set a goal of eliminating viral hepatitis as a public health threat by 2030....

ZERO DISCRIMINATION DAY: FEAR AND IGNORANCE ROBS PEOPLE OF JOBS, EDUCATION OPPORTUNITIES, FRIENDSHIPS AND RELATIONSHIPS

1 Mar 2017 Bridie Taylor

People living with viral hepatitis are subject to stigma and discrimination in almost every aspect of their lives. Fear and ignorance have robbed...

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

World Hepatitis Alliance President-Elect announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President-Elect Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

Pages

News from infohep

Immune modulator inarigivir looks promising for people with hepatitis B

12 Dec 2017 Liz Highleyman
Inarigivir, or SB 9200, an immune-modulating drug that has a dual mechanism of action against hepatitis B virus (HBV), reduced levels of HBV DNA, RNA...

TAF for hepatitis B improves kidney function and bone loss

30 Nov 2017 Liz Highleyman
Tenofovir alafenamide (TAF) remains effective against hepatitis B virus (HBV) for 96 weeks, with no resistance detected, according to studies...

REP 2139 combination therapy leads to functional control of hepatitis B virus

29 Nov 2017 Liz Highleyman
A majority of chronic hepatitis B patients treated with a nucleic acid polymer (REP 2139 or REP 2165) plus tenofovir and pegylated interferon were...

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

28 Nov 2017 Liz Highleyman
An 8-week course of sofosbuvir/ledipasvir (Harvoni) led to a sustained response in all people with HIV and genotype 1 or 4 hepatitis C virus (HCV) in...

US approves new hepatitis B vaccine as public health agencies update guidelines

27 Nov 2017 Liz Highleyman
On 9 November the US Food and Drug Administration (FDA) approved Heplisav-B, a new vaccine that provides protection against all known subtypes of...

Model shows hepatitis C treatment is cost-effective in Japan

27 Nov 2017 Liz Highleyman
Treatment of chronic hepatitis C with direct-acting antivirals (DAAs) can lead to substantial savings by preventing the development of liver failure...

More work and lower drug prices are needed to eliminate hepatitis C worldwide

27 Nov 2017 Liz Highleyman
Eliminating hepatitis C virus (HCV) as a global public health concern is feasible, but to do this more people need to be tested and treated and...

Nivolumab improves outcomes in liver cancer study

13 Nov 2017 Liz Highleyman
Nivolumab (Opdivo), a PD-1 checkpoint inhibitor that helps the immune system fight cancer, was associated with a decrease in tumour size or disease...

High rate of hepatitis C reinfection in German men who have sex with men

3 Nov 2017 Keith Alcorn
Around one in seven gay and bisexual men cured of hepatitis C at major treatment centres in Germany has become reinfected since 2014, according to...

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

2 Nov 2017 Keith Alcorn
Nine countries – Australia, Brazil, Egypt, Georgia, Germany, Iceland, Japan, the Netherlands and Qatar – are on course to eliminate hepatitis C by...